Effects of trazodone on neurotransmitter release from rat mossy fibre cerebellar synaptosomes

European Journal of Pharmacology

Volumn 400, Issue 1, 2000, Pages 35-41

  Garrone, Beatrice ^a   Magnani, Maurizio ^a   Pinza, Mario ^a   Polenzani, Lorenzo ^a  

^a Università Politecnica delle Marche ACRAF Gruppo Angelini   (Italy)

Author keywords

Cerebellum; GABA ( aminobutyric acid) release; Glutamate release; Synaptosome; Receptor

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMIC ACID; N [2 (2,3 DICHLOROPHENYL)ETHYL] 2 DIMETHYLAMINO N METHYLETHYLAMINE; N ALLYLNORMETAZOCINE; OPIATE RECEPTOR AFFECTING AGENT; POTASSIUM CHLORIDE; PRECLAMOL; SEROTONIN; SIGMA OPIATE RECEPTOR; TRAZODONE; UNCLASSIFIED DRUG;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL CELL; ARTICLE; BRAIN SYNAPTOSOME; CEREBELLUM; CONCENTRATION RESPONSE; CONTROLLED STUDY; MALE; MOSSY FIBER; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CEREBELLUM; ETHYLENEDIAMINES; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; MALE; NERVE FIBERS; PHENAZOCINE; PIPERIDINES; POTASSIUM CHLORIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SIGMA; SEROTONIN; SYNAPTOSOMES; TRAZODONE;

EID: 0034648055     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00378-2     Document Type: Article

References (37)

1. 2C receptor protein in human and rat brains using specific antisera. Neuropharmacology. 34:1995;1635-1645.
2. 1 binding sites in guinea pig brain. Eur. J. Pharmacol. 251:1994;R1-R2.
3. DeCoster M.A., Klette K.L., Knight E.S., Tortella F.C. σ Receptor-mediated neuroprotection against glutamate toxicity in primary rat neuronal cultures. Brain Res. 671:1995;45-53.
4. Ellis Y., Davies J.A. The effects of sigma ligands on the release of glutamate from rat striatal slices. Naunyn-Schmiedeberg's Arch. Pharmacol. 350:1994;143-148.
5. Faherty C.J., Harkin A.J., Leonard B.E. The functional sensitization of sigma receptors following chronic selective serotonin reuptake inhibitor treatment. Eur. J. Pharmacol. 346:1998;15-21.
6. 3H]dopamine release from rat striatal slices by sigma receptor ligands. J. Pharmacol. Exp. Ther. 271:1994;212-219.
7. Gonzalez-Alvear G.M., Werling L.L. Sigma receptor regulation of norepinephrine release from rat hippocamoal slices. Brain Res. 673:1995;61-69.
8. Gonzalez-Alvear G.M., Thompson-Montgomery D., Deben S.E., Werling L.L. Functional and binding properties of σ receptors in rat cerebellum. J. Neurochem. 65:1995;2509-2516.
9. Hanner M., Moebius F.F., Flandorfer A., Knaus H.G., Striessnig J., Kempner E. Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc. Natl. Acad. Sci. U. S. A. 93:1996;8072-8077.
10. Haria M., Fitton A., McTavish D. Trazodone: a review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders. Drug. 4:1994;1-25.
11. Israel M., Whittaker V.P. The isolation of mossy fiber endings from the granular layer of the cerebellar cortex. Experientia. 1965;325-326.
12. 3H]glutamate binding to NMDA receptors in human cerebellum. Neurosci. Lett. 125:1991;143-149.
13. i protein to block the psychological stress and corticotropin releasing factor-induced colonic motor activation in rats. Neuropharmacology. 30:1991;1119-1124.
14. Kekuda R., Prasad P.D., Fei Y.J., Leibach F.H., Ganapathy V., Fei Y.J. Cloning and functional expression of the human type 1 sigma receptor (hSigma R1). Biochem. Biophys. Res. Commun. 229:1996;553-558.
15. 2 binding in rat brain. Eur. J. Pharmacol. 259:1994;65-69.
16. 2 receptors. Life Sci. 28:1981;1015-1022.
17. Lockart B.P., Soulard P., Benicourt C., Privat A., Junien J.L. Distinct neuroprotective profiles for σ ligands against N-methyl-D-aspartate (NMDA), and hypoxia-mediated neurotoxicity in neuronal culture toxicity studies. Brain Res. 675:1995;110-120.
18. Lysko P.G., Gagnon R.C., Yue T.L., Gu J.L., Feuerstein G. Neuroprotective effects of SKF 10,047 in cultured rat cerebellar neurons and in gerbil global brain ischemia. Stroke. 23:1992;414-419.
19. Lysko P.G., Yue T.L., Gu J.L., Feuerstein G. Neuroprotective mechanisms of (+)SKF 10,047 in vitro and in gerbil global brain ischemia. Stroke. 23:1992;1319-1324.
20. 3H] RP 62203 binding in the rat brain. Eur. J. Pharmacol. 233:1993;37-45.
21. 2C receptors mediating inhibition on the N-methyl-D-aspartate/nitric oxide/cyclic GMP pathway in rat cerebellum. J. Pharmacol. Exp. Ther. 285:1998;983-986.
22. Martin W.R., Eades C.G., Thompson J.A., Huppler R.E., Gilbert P.E. The effects of morphine- and nalorphine-like drugs in the non-dependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197:1976;517-532.
23. Matsuno K., Senda T., Mita S. Correlation between potentiation of neurogenic twitch contraction and benzomorphan σ receptor binding potency in the mouse vas deferens. Eur. J. Pharmacol. 231:1993;451-457.
24. 1 receptor agonist. Eur. J. Pharmacol. 306:1996;271-279.
25. 2 presynaptic receptors mediate inhibition of glutamate release from cerebellar mossy fibre terminals. Eur. J. Pharmacol. 202:1991;185-190.
26. McCann D.J., Weissman A.D., Su T.P. Sigma-1 and sigma-2 sites in rat brain: comparison of regional, ontogenetic, and subcellular patterns. Synapse. 17:1994;182-189.
27. McLean S., Weber E. Autoradiographic visualization of haloperidol-sensitive sigma receptors in guinea pig brain. Neuroscience. 25:1988;259-269.
28. Meyer C., Schmieding K., Falkenstein E., Wehling M. Are high affinity progesterone binding site(s) from porcine liver microsomes members of the sigma receptor family? Eur. J. Pharmacol. 347:1998;293-299.
29. Owens M.J., Morgan W.N., Plott S.J., Nemeroff C.B. Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J. Pharmacol. Exp. Ther. 283:1997;1305-1322.
30. 1 receptor. J. Neurochem. 70:1998;2279-2285.
31. Pazzagli M., Giovannini M.G., Pepeu G. Trazodone increases extracellular serotonin levels in frontal cortex of rats. Eur. J. Pharmacol. 383:1999;249-257.
32. Quirion R., Bowen W.D., Ithzak Y., Junien J.L., Musacchio J.M., Rothman R.B., Su T.B., Tam W., Taylor D.P. A proposal for the classification of sigma binding sites. Trends Pharmacol. Sci. 13:1992;85-86.
33. Raiteri M., Angelini F., Levi G. A simple apparatus for studying the release of neurotransmitters from synaptosomes. Eur. J. Pharmacol. 25:1974;411-414.
34. Seth P., Fei Y.J., Li H.W., Huang W., Leibach F.H., Ganapathy V. Cloning and functional characterization of sigma receptor from rat brain. J. Neurochem. 70(3):1998;922-931.
35. Siniscalchi A., Cristofori P., Veratti A. Influence of N-Allyl-normetazocine on acetylcholine release from brain slices: involvement of muscarinic receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 336:1987;425-429.
36. Tonnaer J.A.D.M., Engels G.M.H., Wiegant V.M., Burbach J.P.H., De Jong W., De Wied D. Proteolytic conversion of angiotensins in rat brain tissue. Eur. J. Biochem. 131:1983;415-421.
37. Walker J.M., Bowen W.D., Walker F.O., Matsumoto R.R., DeCosta B., Rice K.C. Sigma receptor: biology and function. Pharmacol. Rev. 42:1990;355-402.